DM
ELV icon

Delphi Management’s Elevance Health ELV Stock Holding History

Delphi Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,893
Closed -$984K – 87
2024
Q3 		$984K Sell
1,893
-219
-10% -$117K 0.89% 69
2024
Q2 		$1.14M Hold
2,112
– – 0.93% 68
2024
Q1 		$1.09M Buy
2,112
+17
+0.8% +$8.46K 0.85% 71
2023
Q4 		$988K Sell
2,095
-4
-0.2% -$1.85K 0.91% 65
2023
Q3 		$914K Buy
2,099
+10
+0.5% +$4.54K 0.94% 68
2023
Q2 		$928K Buy
+2,089
New +$964K 0.96% 66
2022
Q4 		$1.07M Buy
+2,096
New +$1.06M 1.3% 48
2021
Q4 		$1.38M Buy
2,972
+141
+5% +$59.3K 1.3% 34
2021
Q3 		$1.05M Buy
2,831
+21
+0.7% +$7.98K 1.09% 51
2021
Q2 		$1.07M Sell
2,810
-336
-11% -$128K 1.02% 55
2021
Q1 		$1.13M Buy
+3,146
New +$1.01M 1.2% 45

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Delphi Management's ELV Position: Q4 2024 in Review

Delphi Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,893 shares — an estimated $984K sold.

Delphi Management first reported a position in ELV in Q1 2021 and held it in 11 quarters. The position peaked at $1.38M in Q4 2021. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Delphi Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Delphi Management sold 1,893 Elevance Health shares in Q4 2024, an estimated $984K.
  • Delphi Management first reported a position in Elevance Health in Q1 2021 and held it in 11 quarters.
  • Delphi Management's Elevance Health position peaked at $1.38M in Q4 2021.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Delphi Management's 13F filing for Q4 2024, filed 10 Feb 2025.